Macrophage activation syndrome as the presenting feature of a Hodgkin's lymphoma in an elderly patient;Syndrome d'activation macrophagique révélant une maladie de Hodgkin chez un sujet âgé

Revue de Medecine Interne

Volumn 32, Issue 2, 2011, Pages

  Martinaud, C ^a   Cournac, J M ^a   Pons, S ^a   Gaillard, T ^a   Darles, C ^a   de Jaureguiberry, J P ^a   Brisou, P ^a  

^a Military Teaching Hospital Sainte Anne   (France)

Author keywords

Hodgkin lymphoma; Interleukine 18; Macrophage activation syndrome; SCD25

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 2 RECEPTOR ALPHA;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; FATALITY; HODGKIN DISEASE; HUMAN; IMMUNOASSAY; MACROPHAGE ACTIVATION SYNDROME; MALE;

AGED; FATAL OUTCOME; HODGKIN DISEASE; HUMANS; MACROPHAGE ACTIVATION SYNDROME; MALE;

EID: 78751628308     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2010.03.460     Document Type: Article

References (27)

1. Janka G.E. Hemophagocytic syndromes. Blood Rev 2007, 21:245-253.
2. Henter J.I., Tondini C., Pritchard J. Histiocyte disorders. Crit Rev Oncol Hematol 2004, 50:157-174.
3. Wong K.F., Chan J.K. Reactive hemophagocytic syndrome--a clinicopathologic study of 40 patients in an oriental population. Am J Med 1992, 93:177-180.
4. Tsuda H., Shirono K. Serum lipids in adult patients with hemophagocytic syndrome. Am J Hematol 1996, 53:285.
5. Janka G., zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program 2005, 82-88.
6. Ost A., Nilsson-Ardnor S., Henter J.I. Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis. Histopathology 1998, 32:310-316.
7. Komp D.M., McNamara J., Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 1989, 73:2128-2132.
8. Miossec P. Les récepteurs solubles de l'interleukine 2. Valeur clinique et signification biologique. Presse Med 1991, 20:997-1001.
9. Arend W.P., Palmer G., Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008, 223:20-38.
10. Mazodier K., Marin V., Novick D., Farnarier C., Robitail S., Schleinitz N., et al. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 2005, 106:3483-3489.
11. Emmenegger U., Schaer D.J., Larroche C., Neftel K.A. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 2005, 135:299-314.
12. Francois B., Trimoreau F., Vignon P., Verger G., Gastinne H. Les récepteurs solubles de l'interleukine 2. Valeur clinique et signification biologique. Ann Fr Anesth Reanim 1995, 14:514-516.
13. Kaito K., Kobayashi M., Katayama T., Otsubo H., Ogasawara Y., Sekita T., et al. Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol 1997, 59:247-253.
14. Menard F., Besson C., Rince P., Lambotte O., Lazure T., Canioni D., et al. Hodgkin lymphoma-associated hemophagocytic syndrome: a disorder strongly correlated with Epstein-Barr virus. Clin Infect Dis 2008, 47:531-534.
15. Takahashi N., Chubachi A., Kume M., Hatano Y., Komatsuda A., Kawabata Y., et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol 2001, 74:209-213.
16. Ohshima K., Suzumiya J., Sugihara M., Nagafuchi S., Ohga S., Kikuchi M. Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome. Pathol Int 1998, 48:934-943.
17. Takeshita M., Kikuchi M., Ohshima K., Nibu K., Suzumiya J., Hisano S., et al. Bone marrow findings in malignant histiocytosis and/or malignant lymphoma with concurrent hemophagocytic syndrome. Leuk Lymphoma 1993, 12:79-89.
18. Dawson L., den Ottolander G.J., Kluin P.M., Leeksma O. Reactive hemophagocytic syndrome as a presenting feature of Hodgkin's disease. Ann Hematol 2000, 79:322-326.
19. Mounier N., Cazals D., Pautier P., Morinet F., Cayuela J.M., Gossot D., et al. EBV reactivation associated with Hodgkin's disease relapse and fatal hemophagocytic syndrome. Leukemia 1996, 10:1848.
20. Chan K., Behling E., Strayer D.S., Kocher W.S., Dessain S.K. Prolonged hemophagocytic lymphohistiocytosis syndrome as an initial presentation of Hodgkin lymphoma: a case report. J Med Case Reports 2008, 2:367.
21. Kojima H., Takei N., Mukai Y., Hasegawa Y., Suzukawa K., Nagata M., et al. Hemophagocytic syndrome as the primary clinical symptom of Hodgkin's disease. Ann Hematol 2003, 82:53-56.
22. Soiza R.L., Ghosh S., McAlpine J.K., Vickers M.A. Non-fatal haemophagocytic syndrome in an elderly patient. Age Ageing 2005, 34:522-524.
23. Hasselblom S., Linde A., Ridell B. Hodgkin's lymphoma, Epstein-Barr virus reactivation and fatal haemophagocytic syndrome. J Intern Med 2004, 255:289-295.
24. Chim C.S., Hui P.K. Reactive hemophagocytic syndrome and Hodgkin's disease. Am J Hematol 1997, 55:49-50.
25. Henter J.I., Horne A., Arico M., Egeler R.M., Filipovich A.H., Imashuku S., et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007, 48:124-131.
26. Bellas C., Santon A., Manzanal A., Campo E., Martin C., Acevedo A., et al. Pathological, immunological, and molecular features of Hodgkin's disease associated with HIV infection. Comparison with ordinary Hodgkin's disease. Am J Surg Pathol 1996, 20:1520-1524.
27. Rigaud S., Fondaneche M.C., Lambert N., Pasquier B., Mateo V., Soulas P., et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006, 444:110-114.